Even higher use seen in patients without type 2 diabetes. (HealthDay News) — The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) before surgery rose 16-fold among patients undergoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results